Retractable Technologies (RVP) versus Its Competitors Head-To-Head Comparison

Retractable Technologies (NYSE:RVPGet Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Retractable Technologies to similar businesses based on the strength of its institutional ownership, dividends, earnings, risk, valuation, analyst recommendations and profitability.

Insider & Institutional Ownership

23.7% of Retractable Technologies shares are owned by institutional investors. Comparatively, 50.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 49.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 14.3% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Retractable Technologies and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Retractable Technologies $188.38 million $56.06 million 2.31
Retractable Technologies Competitors $1.15 billion $84.78 million -14.40

Retractable Technologies’ rivals have higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Retractable Technologies has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Comparatively, Retractable Technologies’ rivals have a beta of 1.13, suggesting that their average stock price is 13% more volatile than the S&P 500.

Profitability

This table compares Retractable Technologies and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Retractable Technologies 29.76% 70.02% 32.11%
Retractable Technologies Competitors -700.34% -63.67% -17.98%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Retractable Technologies and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies 0 0 0 0 N/A
Retractable Technologies Competitors 1239 4552 7969 221 2.51

As a group, “Surgical & medical instruments” companies have a potential upside of 55.41%. Given Retractable Technologies’ rivals higher probable upside, analysts clearly believe Retractable Technologies has less favorable growth aspects than its rivals.

Summary

Retractable Technologies beats its rivals on 6 of the 10 factors compared.

Retractable Technologies Company Profile (Get Rating)

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.